Back
Speaker illustration

Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)

Member of:

European Society of Cardiology

EXPERIENCES: 2003 - 04 Resident in Medicine, Kanazawa University Hospital, Kanazawa, Japan 2004 - 05 Clinical Fellow in Cardiology and Internal Medicine Kouseiren Takaoka Hospital, Takaoka, Japan 2005 - 06 Clinical Fellow in Fukui Cardiovascular Center, Fukui, Japan 2006 - 10 Medical Staff in Division of Cardiovascular Medicine Kanazawa University Hospital, Kanazawa, Japan 2011 - 12 Assistant Professor Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan 2012 - 14 Research Scholar Massachusetts General Hospital Center for Human Genetic Research, Boston, MA, USA 2014 - Assistant Professor Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan

Presentations

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks

Event: ESC Congress 2024

Topic: Lipids

Session: Familial hypercholesterolaemia and cardiovascular risk

Access
Like
Thumbnail

Impact of changes of Achilles tendon thickening on cardiovascular events among patients with familial hypercholesterolemia

Event: ESC Congress 2024

Topic: Lipids

Session: Familial hypercholesterolaemia and cardiovascular risk

Access
Like
Thumbnail

Advances in Lp(a) testing and management: from bench to bedside

Event: ESC Congress 2024

Topic: Cardiovascular Risk Assessment

Session: Bridging east and west: a global dialogue on Lp(a)- from epidemiology to clinical practice

Access
Like
Thumbnail

Global variations in Lp(a) epidemiology: understanding the east-west divide

Event: ESC Congress 2024

Topic: Cardiovascular Risk Assessment

Session: Bridging east and west: a global dialogue on Lp(a)- from epidemiology to clinical practice

Access
Like
Thumbnail

Lp(a) and cardiovascular risk: integrating perspectives for a holistic approach

Event: ESC Congress 2024

Topic: Cardiovascular Risk Assessment

Session: Bridging east and west: a global dialogue on Lp(a)- from epidemiology to clinical practice

Access
Like
Thumbnail

Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Access
Like
Thumbnail

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Access
Like
Thumbnail

Impact of coronary artery calcium on the prognosis of heterozygous familial hypercholesterolemia

Event: ESC Congress 2023

Topic: Lipids

Session: Imaging or biomarkers: which is superior in risk prediction?

Access
Like
Thumbnail

Impact of cumulative exposure to LDL cholesterol on cardiovascular events in patients with familial hypercholesterolemia

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Congress committee e-posters choice in preventive cardiology and special populations

Access
Like
Thumbnail

Achilles tendon thickness assessed by X-ray predicting a pathogenic mutation in familial hypercholesterolemia gene

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources